Better affordability of medicines starts with a smarter, more efficient supply chain.
As our in-house manufactured portfolio continues to grow, we are strengthening our ability to simplify supply, leverage production volumes, and deliver high-quality therapies more efficiently.
For Dr. Marie Wiechert, MBA, our Head of In-House Supply Chain, this means connecting the dots across the entire supply chain – from planning and manufacturing to logistics and delivery.
By building stronger in-house capabilities and a more seamless supply chain, we strive to improve efficiency and supply resilience – enabling us to make high-quality medicines more affordable for patients worldwide.
A smarter supply chain is not just about efficiency. It is about creating sustainable value for our partners, our business – and, most importantly, our patients.
